# Incretin Effect in PCOS Women

> **NCT01892254** · PHASE4 · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 20 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01892254
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2017-11-23
- **Final completion:** 2017-11-23
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01892254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01892254, "Incretin Effect in PCOS Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01892254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*